The Executive Director, Business Development & Strategic Client Relationships is responsible for driving growth through strategic Sponsor partnerships and early-phase (Phase I - 2) clinical development opportunities. This executive-level role focuses on building long-term, high-value relationships directly with pharmaceutical sponsors and biotechnology companies engaged in developing assets in ERG’s core therapeutic areas (CNS, Cardio-Metabolic, Pain) with a particular focus on assets entering first-in-human and early proof-of-concept trials.
The Executive Director serves as a senior commercial leader and ambassador for ERG and Lotus, aligning sponsor needs with the company’s internal infrastructure, clinical expertise, and operational strengths.
Key ResponsibilitiesPhase I-2 & Lotus-Focused Business Development• Lead enterprise-level business development efforts focused on Phase I-2 and early development programs, including first-in-human and early proof-of-concept studies.
• Develop and execute engagement strategies to build preferred partnerships and drive repeat business to ERG and Lotus.
• Identify, qualify, and pursue early-phase opportunities aligned with ERG’s therapeutic strengths, capacity, and operational capabilities.
• Maintain market insight into CRO operating models, sponsor pipelines, and early-phase development trends.
• Cultivate long-term, trusted partnerships based on clinical insight, credibility, and consistent delivery.
• Expand relationships through multi-study engagements, preferred site models, and early pipeline visibility.
• Represent ERG and Lotus at industry conferences and sponsor meetings as a senior spokesperson.
• Support development of complex client proposals, including feasibility assessments, budgets, timelines, and capacity planning.
• Collaborate closely with clinical operations, medical leadership, finance, and feasibility teams to ensure commercially sound proposals.
• Support pricing strategy and negotiations while ensuring alignment with internal delivery standards and risk tolerance.
• Maintain disciplined opportunity tracking, forecasting, and reporting using Lotus and EG CRM systems.
• Partner with internal stakeholders to translate CRO and sponsor requirements into operational and strategic priorities.
• Provide market feedback to inform Phase I capability development, site expansion, and service differentiation.
• Influence cross-functional alignment to support seamless execution from opportunity identification through study start-up.
• Bachelor’s degree in business, life sciences, healthcare, or a related field required.
• Advanced degree (MBA, Master’s, or PhD) strongly preferred.
• 8–10+ years of progressive business development or strategic partnership experience within a CRO, clinical research site network, or early-phase clinical research organization.
• Demonstrated success managing complex Phase I sales cycles and executive-level relationships.
• Deep understanding of Phase I clinical development and CRO engagement models.
• Executive-level communication, presentation, and negotiation skills.
• Strategic thinker with strong commercial judgment and market awareness.
• Ability to influence cross-functional teams without direct authority.
• Proficiency with CRM platforms (i.e. Salesforce, Devana)
• Willingness to travel for CRO meetings, sponsor engagements, and industry events.
Additional Information
This position may evolve to reflect the company’s strategic growth objectives and early-phase development focus. This job description outlines the general scope and level of responsibility and is not intended to be an exhaustive list of duties.
Similar Jobs
What you need to know about the Colorado Tech Scene
Key Facts About Colorado Tech
- Number of Tech Workers: 260,000; 8.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Lockheed Martin, Century Link, Comcast, BAE Systems, Level 3
- Key Industries: Software, artificial intelligence, aerospace, e-commerce, fintech, healthtech
- Funding Landscape: $4.9 billion in VC funding in 2024 (Pitchbook)
- Notable Investors: Access Venture Partners, Ridgeline Ventures, Techstars, Blackhorn Ventures
- Research Centers and Universities: Colorado School of Mines, University of Colorado Boulder, University of Denver, Colorado State University, Mesa Laboratory, Space Science Institute, National Center for Atmospheric Research, National Renewable Energy Laboratory, Gottlieb Institute



